Stay updated on Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A banner announces an NIH-wide transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:28:55.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:13:34.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1. The study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:01:42.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden state with a minimal header and Home button, and a large portion of the previous study-content sections has been removed, resulting in an error-page display rather than the full study details.
    Difference
    19%
    Check dated 2026-09-20T22:12:42.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The study record page shows a version bump from v3.6.5 to v3.6.6, indicating a minor backend update rather than changes to study content.
    Difference
    0.1%
    Check dated 2026-08-30T15:56:06.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This reflects a small platform update applied to the page.
    Difference
    0.1%
    Check dated 2026-08-08T23:28:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page.